Cargando…

Factors associated with the informal use of HIV pre‐exposure prophylaxis in Germany: a cross‐sectional study

INTRODUCTION: Until September 2019, pre‐exposure prophylaxis (PrEP) with tenofovir disoproxil/emtricitabine for HIV prevention was not covered by health insurance plans in Germany, and was only available through private prescriptions with self‐pay or through informal non‐prescription sources. The ob...

Descripción completa

Detalles Bibliográficos
Autores principales:	Koppe, Uwe, Marcus, Ulrich, Albrecht, Stefan, Jansen, Klaus, Jessen, Heiko, Gunsenheimer‐Bartmeyer, Barbara, Bremer, Viviane
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2019
Materias:	Research Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6776824/ https://www.ncbi.nlm.nih.gov/pubmed/31583823 http://dx.doi.org/10.1002/jia2.25395

Ejemplares similares

Barriers to using HIV pre-exposure prophylaxis (PrEP) and sexual behaviour after stopping PrEP: a cross-sectional study in Germany
por: Koppe, Uwe, et al.
Publicado: (2021)

HIV, STI and renal function testing frequency and STI history among current users of self-funded HIV pre-exposure prophylaxis, a cross-sectional study, Germany, 2018 and 2019
por: Koppe, Uwe, et al.
Publicado: (2022)

Transmitted drug resistance and subtype patterns of viruses from reported new HIV diagnoses in Germany, 2017–2020
por: Fiebig, Uwe, et al.
Publicado: (2023)

The impact of regional socioeconomic deprivation on the timing of HIV diagnosis: a cross-sectional study in Germany
por: Pantke, Annemarie, et al.
Publicado: (2022)

Cost-effectiveness and budget effect of pre-exposure prophylaxis for HIV-1 prevention in Germany from 2018 to 2058
por: van de Vijver, David A M C, et al.
Publicado: (2019)

Analysis of HIV pre-exposure prophylaxis (PrEP) needs and PrEP use in Germany among men who have sex with men
por: Marcus, Ulrich, et al.
Publicado: (2022)

Characterization of a hepatitis C virus genotype 1 divergent isolate from an HIV-1 coinfected individual in Germany assigned to a new subtype 1o
por: Wang, Bo, et al.
Publicado: (2019)

High Prevalence and High Incidence of Coinfection with Hepatitis B, Hepatitis C, and Syphilis and Low Rate of Effective Vaccination against Hepatitis B in HIV-Positive Men Who Have Sex with Men with Known Date of HIV Seroconversion in Germany
por: Jansen, Klaus, et al.
Publicado: (2015)

Optimization of HIV testing services in Germany using HIV indicator diseases: study protocol of the HeLP study
por: Valbert, Frederik, et al.
Publicado: (2023)

HIV pre-exposure prophylaxis was associated with no impact on sexually transmitted infection prevalence in a high-prevalence population of predominantly men who have sex with men, Germany, 2018 to 2019
por: Streeck, Hendrik, et al.
Publicado: (2022)

Increased incidence of syphilis in men who have sex with men and risk management strategies, Germany, 2015
por: Jansen, Klaus, et al.
Publicado: (2016)

National molecular surveillance of recently acquired HIV infections in Germany, 2013 to 2014
por: Hauser, Andrea, et al.
Publicado: (2017)

HIV-Prevalence in Tuberculosis Patients in Germany, 2002–2009: An Estimation Based on HIV and Tuberculosis Surveillance Data
por: Fiebig, Lena, et al.
Publicado: (2012)

STI in times of PrEP: high prevalence of chlamydia, gonorrhea, and mycoplasma at different anatomic sites in men who have sex with men in Germany
por: Jansen, Klaus, et al.
Publicado: (2020)

Prevalence and persistence of transmitted drug resistance mutations in the German HIV-1 Seroconverter Study Cohort
por: Machnowska, Patrycja, et al.
Publicado: (2019)

A shift from travel-associated cases to autochthonous transmission with Berlin as epicentre of the monkeypox outbreak in Germany, May to June 2022
por: Selb, Regina, et al.
Publicado: (2022)

Recommendation for post-exposure prophylaxis after potential exposure to herpes b virus in Germany
por: Remé, Thomas, et al.
Publicado: (2009)

Increasing proportions of HIV-1 non-B subtypes and of NNRTI resistance between 2013 and 2016 in Germany: Results from the national molecular surveillance of new HIV-diagnoses
por: Hauser, Andrea, et al.
Publicado: (2018)

Low incidence of HIV infection and decreasing incidence of sexually transmitted infections among PrEP users in 2020 in Germany
por: Schmidt, Daniel, et al.
Publicado: (2022)

Surveillance of recent HIV infections among newly diagnosed HIV cases in Germany between 2008 and 2014
por: Hofmann, Alexandra, et al.
Publicado: (2017)

Pre-exposure Prophylaxis (PrEP) Information on Instagram: Content Analysis
por: Walsh-Buhi, Eric, et al.
Publicado: (2021)

Pre-exposure prophylaxis of HIV
por: Naswa, Smriti, et al.
Publicado: (2011)

Pre-exposure prophylaxis in HIV
por: Khambhati, Ravi, et al.
Publicado: (2009)

HIV: Pre-exposure Prophylaxis
por: Singh, Ajai Kumar, et al.
Publicado: (2012)

Experiences of Pre-Exposure Prophylaxis Stigma, Social Support, and Information Dissemination Among Black and Latina Transgender Women Who Are Using Pre-Exposure Prophylaxis
por: Brooks, Ronald A., et al.
Publicado: (2019)

Rabies post-exposure prophylaxis in Germany − What are the challenges?
por: Meyerhoff, P., et al.
Publicado: (2021)

Markedly decreasing azithromycin susceptibility of Neisseria gonorrhoeae, Germany, 2014 to 2021
por: Selb, Regina, et al.
Publicado: (2021)

Tuberculosis among people living with HIV/AIDS in the German ClinSurv HIV Cohort: long-term incidence and risk factors
por: Karo, Basel, et al.
Publicado: (2014)

CD4-cell counts and presence of AIDS in HIV-positive patients entering specialized care—a comparison of migrant groups in the German ClinSurv HIV Cohort Study, 1999–2013
por: Zeitlmann, Nadine, et al.
Publicado: (2016)

Why Do HIV Pre-Exposure Prophylaxis Users Discontinue Pre-Exposure Prophylaxis Care? A Mixed Methods Survey in a Pre-Exposure Prophylaxis Clinic in Belgium
por: Vanbaelen, Thibaut, et al.
Publicado: (2022)

Not again! Effect of previous test results, age group and reason for testing on (re-)infection with Chlamydia trachomatis in Germany
por: Lang, Alexandra Sarah, et al.
Publicado: (2018)

HIV pre-exposure prophylaxis for women
por: Sheth, Anandi N, et al.
Publicado: (2016)

Pre-exposure Prophylaxis: The Delivery Challenge
por: Venter, Willem D. F.
Publicado: (2018)

Modeling HIV Pre-Exposure Prophylaxis
por: Straubinger, Thomas, et al.
Publicado: (2020)

Prescribing pre-exposure prophylaxis for HIV
por: Bloch, Mark
Publicado: (2020)

Comparing Self-Report Pre-Exposure Prophylaxis Adherence Questions to Pharmacologic Measures of Recent and Cumulative Pre-Exposure Prophylaxis Exposure
por: Blumenthal, Jill, et al.
Publicado: (2019)

Pre-Exposure Prophylaxis for HIV Prevention: Safety Concerns
por: Tetteh, Raymond A., et al.
Publicado: (2017)

First Line Treatment Response in Patients with Transmitted HIV Drug Resistance and Well Defined Time Point of HIV Infection: Updated Results from the German HIV-1 Seroconverter Study
por: zu Knyphausen, Fabia, et al.
Publicado: (2014)

Pre-exposure and Post-exposure Prophylaxis for Dog Bites
por: Joob, Beuy, et al.
Publicado: (2017)

Health Information on Pre-Exposure Prophylaxis From Search Engines and Twitter: Readability Analysis
por: Park, Albert, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_ip9ktj1um70v32lhfrhken06g9